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   Experimental bladder tumors were induced in rat by oral administration ofBBN and investigations．
were perf｛）rmed concerning histological changes in the bladder and changes with time i郎he皿itogcn
response of the lymphocytes o’f rats treated with carcinogen and immunostimulating agent． BBN
was dissolved in deionized water as a O．05％ solution and administered， ad libitum， to the Fischer
Strain Rats for 12 weeks． Levamisole was used as immunostimulating agent．
    180 rqts were devided to 6 groups． The first group was a control group which did not receive
nei・ther BBN noy Levarpisoie． ・ The second group receivcd BBN only and the 3－6th groups received
beth BBN and Levamisole．
   The third group received Levamisole at a dose of 1 mg／kg of bedy weight every day from 8 to
25 weeks after the beginning of experiment． The 4－6th groups received at a dose of 1， 3 and 8 mg／kg
every’Eday from 12 to 25 weeks．
   Lymphocytes from the second group Which received BBN only had a lower response to mitogen
than the first group． Lymphocytes from the 3－5th groups which received low dose of Levamisole
had a higher response to mitogen than the second group． These were as well as the first group．’ But
Iymphocytes from the 6th group which received high dose of Levamisole did not have an increased
response tQ mltogen．
   ’At 25 Weeks after the beginning of experiment， any animals of the first group did not deyeiop
b14dder tumor， and all animals of the second and the 6th groups had bladder tumors． 430／． of the
third group） 270／，’ ofthe 4th group and 180／． of the 5th group showed no appearance of bladder tumors．
Key words： Experimental bladder tumor， Cell－rpediated iMmunity， Carcinogenesis， lmmunostim一
           皿ulating agent， LevaTniS・1e
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B．B．N．（N－butyl－N－butanol－4Hydroxy－nitrosamine）
         Fig． 1
   o
     ．’〉’ ［Nxb，．．i ．
Levamisole（L－tetramisole， Levo－2， 3， 5， 6

































suspension をつくり Hank，s液（Gibco Grand Isl一
Table l．．実験材料
1。窯験動物；Fischen孤館ラット，系統名CRJ：CDF（F’344）．．
       5週令，体重95～105g，180匹，日本チャールズ・リバK，K，
       より購入。
2．発癌物質；N・butyl・N・butanol・4hydroxy nitrosamine（BBN）




Group 2 10，0． 5． ％． BBpa Without Levamiso16
Group 3 O．05％ BBN・ Levamisole 工MG／KG
Group 4 ．Q，O．5．％．．B．B．N Levamisole 1 MG／KG
Group 5 O．05％ BBN Levamisole 3 MG／KG




O．05％ BBN in drinking water
16
 Levamisole P，O． daily




Each organ was minced with scissors and the tissue fragments screened through
60Lmesh stainless steel gauze in’to Hanks ＄olution
The cells were drawn through a 25 gauge needle to produce single cell suspension
                        昌The cells were washed by Hahks soiution 3 times
single celi suspension 1 ×10e／mi into the tissue culture medium
                             medium ； RPMI－1640
added mitogensitzth．E ． va 1090 humam AB serumN
1 90 1－glutamine
  microtest plate （Falcon 3040）
       2 ×10”／well
                37eC， 48 hrs CO2 incubater
              ＜麺1μCi／well of 3H一圏「hymidine
                37℃， 24hrs CO2 incubater
harvested by Mark 11 cell－harvester




液はR？MI l640（Gibco Grand Island N・Y・．）に10
％非働化ヒトAB型血清および1％1－Glutamineを
加えたものである・この細胞浮遊液をMicrQtest plate

















































Table 2． Organ weight （g）
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Fig． 9． Spleen cell response to LPS
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Fig． 15． The effect of levamisole on thymocyte response to the mitogen （Group 1）
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The effet of levamisole on thyMocyte response to the mitog6n （Group 2）
Table 3
No． of lncidence of lncidence of

























O／10 （ O 70）
，12113 （ 92％）
5114 （ 36 70）
9115’i 60 7e）
5／11 （．45％）











長所は96個のwellをもち， l we11あたり0・2 ml培
養液中にて1～2×105個位のリンパ球数で培養でき
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      症状により適宜増減。
      慢性肝疾患には，
               健保略称 強ミノC
  ●適応症       ，
   アレルギー性疾患（喘息，奪麻疹，湿疹，ス
   トロフルス，アレルギー性鼻炎など）。食中毒。
  薬物中毒，薬物過敏症，口内炎。
   慢性肝疾患における肝機能異常の改善。
5ml，または20ml）を皮下または静脈内に注射。
1日1回，40mlを静脈内に注射。年齢，症状により適宜増減』
   包装20ml 5管・30管，5ml 5管。50管，2皿Z 10管・100管
       崇使用上の注意は，製品の添付文書をご参照下さい．
健保適用
   餉服麟には』曜盟督 1口7；錠二号
                     包装 1000錠，5000錠
購雛ミノファーゲン製薬本舗（〒160）東京都新宿区新宿3－1－12
